Evidence map›Paper›PMID 34827592›Full record

ReviewBiomolecules2021

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review.

Lucrezia Togni, Marco Mascitti, Davide Sartini, Roberto Campagna, Valentina Pozzi, Eleonora Salvolini, Annamaria Offidani, Andrea Santarelli, Monica Emanuelli

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 31 citations in OpenAlex.

  1. The Sirtuin Network: Linking NADDiabetes/metabolism research and reviews · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Special Issue "Ovarian Cancer: Advances on Pathophysiology and Therapies".International journal of molecular sciences · 2024
    Article
  10. Article
  11. Special Issue "Physiology and Pathophysiology of Placenta 2.0".International journal of molecular sciences · 2024
    Article
  12. Inhibitors of NADInternational journal of molecular sciences · 2024
    Review
  13. Role of SLC7A11/xCT in Ovarian Cancer.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Review
  16. Review
  17. Epigenetic Modulators as Therapeutic Agents in Cancer.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Ovarian Cancer: Advances in Pathophysiology and Therapies.International journal of molecular sciences · 2023
    Article
  20. The Role of NQO1 in Ovarian Cancer.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lucrezia TogniDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Marco MascittiDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.ORCID 0000-0002-7304-3752
Davide SartiniDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Roberto CampagnaDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.ORCID 0000-0003-2607-2734
Valentina PozziDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Eleonora SalvoliniDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.ORCID 0000-0003-2405-8947
Annamaria OffidaniDepartment of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Andrea SantarelliDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.ORCID 0000-0003-4218-3354
Monica EmanuelliDepartment of Clinical, Specialistic and Dental Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Marche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The head and neck tumors (HNT) are a heterogeneous group of diseases ranging from benign to malignant lesions, with distinctive molecular and clinical behaviors. Several studies have highlighted the presence of an altered metabolic phenotype in HNT, such as the upregulation of nicotinamide N-methyltransferase (NNMT). However, its biological effects have not been completely disclosed and the role of NNMT in cancer cell metabolism remains unclear. Therefore, this comprehensive review aims to evaluate the available literature regarding the biological, diagnostic, and prognostic role of NNMT in HNT. NNMT was shown to be significantly overexpressed in all of the evaluated HNT types. Moreover, its upregulation has been correlated with cancer cell migration and adverse clinical outcomes, such as high-pathological stage, lymph node metastasis, and locoregional recurrences. However, in oral squamous cell carcinoma (OSCC) these associations are still debated, and several studies have failed to demonstrate the prognostic significance of NNMT. The shRNA-mediated gene silencing efficiently suppressed the NNMT gene expression and exhibited a clear inhibitory effect on cell proliferation, promoting the expression of apoptosis-related proteins and modulating the cell cycle. NNMT could represent a new molecular biomarker and a new target of molecular-based therapy, although further studies on larger patient cohorts are needed to explore its biological role in HNT.

Indexed as

Head and Neck NeoplasmsNicotinamide N-MethyltransferaseApoptosisBiomarkers, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansPrognosisBiomarkers, TumorNicotinamide N-MethyltransferaseNNMT protein, humandiagnostic markeresophageal squamous cell carcinomahead and neck tumornicotinamidenicotinamide N-methyltransferaseoral squamous cell carcinomaprognosisthyroid cancer

Identifiers

PMID34827592
PMCPMC8615955
OpenAlexW3211242860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.